RHYTHM PHARMACEUTICALS, INC. Intellectual Property Contracts & Agreements
6 Contracts & Agreements
- License Agreements (6 contracts)
- Exclusive License Agreement, dated January 4, 2024, by and between Rhythm Pharmaceuticals, Inc. and LG Chem, Ltd (Filed With SEC on February 29, 2024)
- License Agreement, dated December 3, 2021, by and between the Registrant and RareStone Group Ltd (Filed With SEC on March 1, 2022)
- License Agreement dated March 30, 2018, by and between the Company and Takeda Pharmaceutical Company Limited (Filed With SEC on May 14, 2018)
- License Agreement dated January 4, 2016, by and between the Registrant and Camurus AB (Filed With SEC on September 25, 2017)
- License Agreement dated January 4, 2016, by and between the Registrant and Camurus AB (Filed With SEC on September 5, 2017)
- License Agreement, dated March 21, 2013, by and between the Registrant (f/k/a Rhythm Metabolic, Inc.) and Ipsen Pharma S.A.S (Filed With SEC on September 5, 2017)
